Table 1

Univariate summary statistics of first-dose hydroxyurea pharmacokinetics in 87 children with SCA

VariableMeanSDMedianMinimumMaximumCV (%)
AUC [inf], μg·h/mL 92.98 23.37 94.66 40.89 150.34 25.1 
CL/F, L/h 6.92 3.17 6.46 1.57 21.59 45.8 
CL/F, L/h per kg 0.24 0.09 0.21 0.12 0.80 37.5 
Cmax, μg/mL 26.13 6.83 25.40 12.85 45.48 26.1 
Half-life, h 1.70 0.53 1.67 0.65 3.05 31.2 
MRT, h 3.17 0.78 2.99 2.08 6.08 24.6 
Tmax, h 0.82 0.47 0.57 0.25 2.20 57.3 
V/F, L 12.09 7.59 10.86 2.50 52.44 62.8 
VariableMeanSDMedianMinimumMaximumCV (%)
AUC [inf], μg·h/mL 92.98 23.37 94.66 40.89 150.34 25.1 
CL/F, L/h 6.92 3.17 6.46 1.57 21.59 45.8 
CL/F, L/h per kg 0.24 0.09 0.21 0.12 0.80 37.5 
Cmax, μg/mL 26.13 6.83 25.40 12.85 45.48 26.1 
Half-life, h 1.70 0.53 1.67 0.65 3.05 31.2 
MRT, h 3.17 0.78 2.99 2.08 6.08 24.6 
Tmax, h 0.82 0.47 0.57 0.25 2.20 57.3 
V/F, L 12.09 7.59 10.86 2.50 52.44 62.8 

AUC is the total drug exposure (serum concentration over time) either until the final time point (tf) or extrapolated to infinity (inf), the difference between those two (extra), and D is dose.

CL/F indicates apparent oral clearance; Cmax, the maximum concentration; MRT, mean residence time (average time drug resides in the body); Tmax, time to Cmax; and V/F, apparent volume of distribution.

Close Modal

or Create an Account

Close Modal
Close Modal